HC Wainwright Reiterates Buy Rating on Palisade Bio, Sets $7 Target
HC Wainwright & Co. reiterated its Buy rating on Palisade Bio and a $7.00 price target. The target implies 340.3% upside from the Oct. 12 close of $1.59.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.